A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Area of Science:

• Endocrinology
• Reproductive Biology
• Metabolic Disorders

Background:

• Hyperandrogenemia is central to female reproductive and metabolic health, and a key feature of polycystic ovary syndrome (PCOS).
• A clinically relevant, lean mouse model mimicking PCOS in women is needed for research.
• Existing models may not fully capture the lean phenotype observed in some PCOS patients.

Purpose of the Study:

• To develop and characterize a lean mouse model that accurately replicates key aspects of human PCOS.
• To investigate the reproductive and metabolic consequences of induced hyperandrogenemia in a lean mouse model.
• To assess the impact of this PCOS-like model on offspring development.

Main Methods:

• Sustained hyperandrogenemia was induced in female mice via monthly implantation of dihydrotestosterone (DHT) crystal powder pellets.
• Serum DHT levels were measured to confirm successful induction (2-fold increase compared to controls).
• Reproductive parameters (infertility) and metabolic function were assessed, alongside body weight and composition analysis.

Main Results:

• The DHT-treated mice developed a PCOS-like phenotype characterized by reproductive and metabolic dysfunction.
• Crucially, these changes occurred without significant alterations in body weight or body composition, maintaining a lean phenotype.
• While most mice were infertile, a subset conceived, and their offspring exhibited delayed puberty and elevated adult testosterone levels.

Conclusions:

• This DHT-induced lean mouse model effectively mimics key features of human PCOS, including hyperandrogenemia and associated dysfunctions.
• The model is valuable for studying PCOS pathophysiology and the long-term effects on offspring exposed to a PCOS-like environment in utero.
• Further research using this model can elucidate mechanisms underlying PCOS and inform potential therapeutic strategies.